The consequences of suddenly stopping methylprednisolone vary from person to person due to differences in individual constitution. Some patients may experience adrenal insufficiency, which is mainly manifested as fatigue, loss of appetite, nausea and vomiting, low blood pressure, etc. Some patients may experience a recurrence of the disease after stopping the drug. Therefore, after using it for a certain period of time, if the symptoms are relieved, patients should stop using it or switch to other treatment methods. If there is no improvement in symptoms after long-term use, the drug should be gradually reduced and cannot be stopped suddenly. Methylprednisolone tablets can be used for non-endocrine disorders.
1. Rheumatic diseases: Used as adjunctive therapy for short-term use in psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis, acute or subacute bursitis of ankylosing spondylitis, acute nonspecific tenosynovitis, acute gouty arthritis, post-traumatic osteoarthritis, synovitis of osteoarthritis caused by synovitis of the upper ankle.
2. Collagen diseases: Used in critical illness or as maintenance treatment for the following diseases: systemic lupus erythematosus, generalized dermatomyositis, rheumatic polymyalgia, giant cell arthritis, acute rheumatic myocarditis.
3. Skin diseases: pemphigus, bullous pemphigoid dermatitis, severe various erythema diseases, exfoliative dermatitis, tinea-like fungal diseases, severe psoriasis, severe seborrheic dermatitis.
4. Allergic conditions: Used to control severe or functionally disabling allergic diseases that are difficult to manage with conventional therapy, such as seasonal or perennial allergic rhinitis, serum sickness, bronchial asthma, drug allergy reactions, contact dermatitis, atopic dermatitis.